Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

R. Buhl, M. Solèr, J. Matz, R. Townley, J. O'Brien, O. Noga, K. Champain, H. Fox, J. Thirlwell, G. Della Cioppa

Research output: Contribution to journal › Article › peer-review